What We Mean When We Say 'Race Is a Social Construct'
By Ta-Nehisi Coates,
The Atlantic
| 05. 15. 2013
Andrew Sullivan and Freddie Deboer have two pieces up worth checking out. I disagree with Andrew's (though I detect some movement in his position.) Freddie's piece is
entitled "Precisely How Not to Argue About Race and IQ." He writes:
The problem with people who argue for inherent racial inferiority is not that they lie about the results of IQ tests, but that they are credulous about those tests and others like them when they shouldn't be; that they misunderstand the implications of what those tests would indicate even if they were credible; and that they fail to find the moral, analytic, and political response to questions of race and intelligence.
I think this is a good point, but I want to expand it. Most of the honest writing I've seen on "race and intelligence" focuses on critiquing the idea of "intelligence." So there's lot of good literature on whether it can be measured, its relevance in modern society, whether intelligence changes across generations, whether it changes with environment, and what we mean when we say IQ. As Freddie mentions
here...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...